Embark Holdings Inc. Acquires Muscle Warfare, Inc. As A Wholly Owned Subsidiary
Year-Ended 2011 Year-Ended 2012
Net Sales $1,902,583.00 $1,613,232.00
COGS $1,044,125.00 $966,391.00
Operating Expenses $1,039,661.00 $1,171,105.00Net Income ( $181,203.00) ($ 524,264.00) The Sports Nutrition Market is among the fastest growing and was one of the most resilient markets since the 2007 market downturn, experiencing impressive growth during this entire period. This strong and rapid market growth is forecasted by experts to continue for years to come due to continued and growing use and promotion of these products by elite professional athletes and bodybuilders. In addition, the amateur athlete market continues to expand and grow which is increasing the use of these products; this segment is expected to exceed $6 billion by 2018 according to the most recent Consumer Trend Reports. Daniel Amato, President and CEO of Embark Holdings, Inc. and Muscle Warfare, Inc. stated "I am very excited about the future of both companies and will keep the public informed of the progress. In addition, I would like to inform our shareholders that we have recently subscribed to OTCIQ and within a few weeks plan to be current with OTC Markets and continue to file reports on a quarterly basis, this is a very exciting time for the company and only the beginning of what I believe will be another success story." About Muscle Warfare, Inc. Muscle Warfare is a cutting edge sports nutrition manufacturer that is passionately driven to create and distribute the absolute highest quality products in the marketplace. Every product we develop has been forged with great experience and focus on maximizing product efficacy for real world results. Furthermore, Muscle Warfare products are rigorously tested by top testing labs to help insure them free of banned substances. We are truly committed to helping all athletes achieve and surpass their highest goals and potential.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts